Suppression of PPARγ through MKRN1-mediated ubiquitination and degradation prevents adipocyte differentiation

Cell Death and Differentiation

Volumn 21, Issue 4, 2014, Pages 594-603

  Kim, J H ^a   Park, K W ^b   Lee, E W ^a   Jang, W S ^b   Seo, J ^a   Shin, S ^a   Hwang, K A ^c   Song, J ^a  

^a Yonsei University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c National Institute of Animal Science   (South Korea)

Author keywords

adipocyte differentiation; MKRN1; PPAR ; ubiquitination

Indexed keywords

ADIPOPHILIN; LYSINE; MAKORIN RING FINGER PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEASOME INHIBITOR; RING FINGER PROTEIN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; COMPARATIVE STUDY; EMBRYO; ENZYME REPRESSION; HALF LIFE TIME; HUMAN; HUMAN CELL; KNOCKOUT GENE; LIPID STORAGE; LUCIFERASE ASSAY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION; WILD TYPE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; HEK293 CELLS; HUMANS; LYSINE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; PPAR GAMMA; RIBONUCLEOPROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; UBIQUITINATION;

EID: 84903368570     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.181     Document Type: Article

References (41)

1. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009; 6: 399-409.
2. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97.
3. Buechler C, Wanninger J, Neumeier M. Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol 2011; 17: 2801-2811.
4. Park KW, Halperin DS, Tontonoz P. Before they were fat: adipocyte progenitors. Cell Metab 2008; 8: 454-457.
5. Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 2011; 12: 722-734.
6. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004; 113: 846-855.
7. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006; 4: 263-273.
8. Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008; 77: 289-312.
9. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell 2007; 131: 242-256.
10. Eguchi J, Yan QW, Schones DE, Kamal M, Hsu CH, Zhang MQ et al. Interferon regulatory factors are transcriptional regulators of adipogenesis. Cell Metab 2008; 7: 86-94.
11. Banerjee SS, Feinberg MW, Watanabe M, Gray S, Haspel RL, Denkinger DJ et al. The Kruppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-gamma expression and adipogenesis. J Biol Chem 2003; 278: 2581-2584.
12. Hu Y, Davies GE. Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation. Phytomedicine 2009; 16: 864-873.
13. Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS. Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 2000; 290: 134-138.
14. van Beekum O, Fleskens V, Kalkhoven E. Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator. Obesity (Silver Spring) 2009; 17: 213-219.
15. Adams M, Reginato MJ, Shao DL, Lazar MA, Chatterjee VK. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 1997; 272: 5128-5132.
16. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V et al. A SUMOylationdependent pathway mediates transrepression of inflammatory response genes by PPARgamma. Nature 2005; 437: 759-763.
17. Hauser S, Adelmant G, Sarraf P, Wright HM, Mueller E, Spiegelman BM. Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation. Journal of Biological Chemistry 2000; 275: 18527-18533.
18. Floyd ZE, Stephens JM. Interferon-gamma-mediated activation and ubiquitin-proteasomedependent degradation of PPARgamma in adipocytes. J Biol Chem 2002; 277: 4062-4068.
19. Kilroy G, Kirk-Ballard H, Carter LE, Floyd ZE. The ubiquitin ligase Siah2 regulates PPARgamma activity in adipocytes. Endocrinology 2012; 153: 1206-1218.
20. Han L, Wang P, Zhao G, Wang H, Wang M, Chen J et al. Upregulation of SIRT1 by 17beta-estradiol depends on ubiquitin-proteasome degradation of PPAR-gamma mediated by NEDD4-1. Protein Cell 2013; 4: 310-321.
21. Kim JH, Park SM, Kang MR, Oh SY, Lee TH, Muller MT et al. Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT. Genes Dev 2005; 19: 776-781.
22. Lee EW, Lee MS, Camus S, Ghim J, Yang MR, Oh W et al. Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. EMBO J 2009; 28: 2100-2113.
23. Ko A, Lee EW, Yeh JY, Yang MR, Oh W, Moon JS et al. MKRN1 induces degradation of West Nile Virus capsid protein by functioning as an E3 ligase. J Virol 2010; 84: 426-436.
24. Lee EW, Kim JH, Ahn YH, Seo J, Ko A, Jeong M et al. Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Nat Commun 2012; 3: 978.
25. Ko A, Shin JY, Seo J, Lee KD, Lee EW, Lee MS et al. Acceleration of gastric tumorigenesis through MKRN1-mediated posttranslational regulation of p14ARF. J Natl Cancer Insti 2012; 104: 1660-1672.
26. Omwancha J, Zhou XF, Chen SY, Baslan T, Fisher CJ, Zheng Z et al. Makorin RING finger protein 1 (MKRN1) has negative and positive effects on RNA polymerase II-dependent transcription. Endocrine 2006; 29: 363-373.
27. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. Mppar-Gamma-2 - tissuespecific regulator of an adipocyte enhancer. Genes Dev 1994; 8: 1224-1234.
28. Mueller E, Smith M, Sarraf P, Kroll T, Aiyer A, Kaufman DS et al. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc Natl Acad Sci USA 2000; 97: 10990-10995.
29. Agostini M, Schoenmakers E, Mitchell C, Szatmari I, Savage D, Smith A et al. Non-DNA binding, dominant-negative, human PPAR gamma mutations cause lipodystrophic insulin resistance. Cell Metab 2006; 4: 303-311.
30. Iwamoto F, Umemoto T, Motojima K, Fujiki Y. Nuclear transport of peroxisome-proliferator activated receptor &alpha. J Biochem 2011; 149: 311-319.
31. Umemoto T, Fujiki Y. Ligand-dependent nucleo-cytoplasmic shuttling of peroxisome proliferator-activated receptors, PPARalpha and PPARgamma. Genes Cells 2012; 17: 576-596.
32. Cutress ML, Whitaker HC, Mills IG, Stewart M, Neal DE. Structural basis for the nuclear import of the human androgen receptor. J Cell Sci 2008; 121: 957-968.
33. Wu Z, Bucher NL, Farmer SR. Induction of peroxisome proliferator- activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol Cell Biol 1996; 16: 4128-4136.
34. Park KW, Waki H, Choi SP, Park KM, Tontonoz P. The small molecule phenamil is a modulator of adipocyte differentiation and PPARgamma expression. J Lipid Res 2010; 51: 2775-2784.
35. Lehrke M, Lazar MA. The many faces of PPARgamma. Cell 2005; 123: 993-999.
36. Charo IF. Macrophage polarization and insulin resistance: PPARgamma in control. Cell Metab 2007; 6: 96-98.
37. Tsai YS, Xu L, Smithies O, Maeda N. Genetic variations in peroxisome proliferatoractivated receptor gamma expression affect blood pressure. Proc Natl Acad Sci USA 2009; 106: 19084-19089.
38. Das SK, Chakrabarti R. Role of PPAR in cardiovascular diseases. Recent Patents Cardiovasc Drug Discov 2006; 1: 193-209.
39. Camus S, Higgins M, Lane DP, Lain S. Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6. FEBS Lett 2003; 536: 220-224.
40. Yang MR, Lee SR, Oh W, Lee EW, Yeh JY, Nah JJ et al. West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus. Cell Microbiol 2008; 10: 165-176.
41. Zhang JW, Tang QQ, Vinson C, Lane MD. Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 2004; 101: 43-47.